메뉴 건너뛰기




Volumn 102, Issue 11, 2005, Pages 4134-4139

HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol

(19)  Hung, Shuen Lu a   Chung, Wen Hung a,b,i   Liou, Lieh Bang b   Chu, Chen Chung c   Lin, Marie c   Huang, Hsien Ping a   Lin, Yen Ling a   Lan, Joung Liang d   Yang, Li Cheng b   Hong, Hong Shang b   Chen, Ming Jing b   Lai, Ping Chin b   Wu, Mai Szu b   Chu, Chia Yu e,f   Wang, Kuo Hsien e,f   Chen, Chien Hsiun a   Fann, Cathy S J a   Wu, Jer Yuarn a,g   Chen, Yuan Tsong a,h  


Author keywords

Adverse drug reactions; Genetic polymorphism; Pharmacogenetics; Stevens Johnson syndrome; Toxic epidermal necrolysis

Indexed keywords

ALLOPURINOL; HLA B ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PROTEIN MSH5; PROTEIN MUTS; UNCLASSIFIED DRUG; ANTIGOUT AGENT; HLA B*5801 ANTIGEN, HUMAN; HLA-B*5801 ANTIGEN, HUMAN;

EID: 15244349566     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0409500102     Document Type: Article
Times cited : (1112)

References (36)
  • 22
    • 15244339011 scopus 로고    scopus 로고
    • eds. Gjertson, D.W. & Terasaki, P.I. (Am. Soc. Histocomp. Immunogenet., Mt. Laurel, NJ)
    • Geer, L., Terasaki, P. I. & Gjertson, D. W. (1998) in HLA 1998, eds. Gjertson, D.W. & Terasaki, P.I. (Am. Soc. Histocomp. Immunogenet., Mt. Laurel, NJ), pp. 352-353.
    • (1998) HLA 1998 , pp. 352-353
    • Geer, L.1    Terasaki, P.I.2    Gjertson, D.W.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.